---
title: "KYMR: Q2 2026 revenue surged, net loss narrowed, and clinical pipeline advanced toward key milestones"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294977444.md"
description: "Clinical pipeline advanced with KT-621 and KT-579, targeting major immunology needs. Q2 2026 revenue rose sharply year-over-year, with net loss narrowing and cash reserves strong. Key data readouts and trial initiations are expected through 2027.Original document: Kymera Therapeutics, Inc. [KYMR] Slides Release — Aug. 5 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-05T13:44:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294977444.md)
  - [en](https://longbridge.com/en/news/294977444.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294977444.md)
generator: "portal-rs"
---

# KYMR: Q2 2026 revenue surged, net loss narrowed, and clinical pipeline advanced toward key milestones

Clinical pipeline advanced with KT-621 and KT-579, targeting major immunology needs. Q2 2026 revenue rose sharply year-over-year, with net loss narrowing and cash reserves strong. Key data readouts and trial initiations are expected through 2027.

Original document: Kymera Therapeutics, Inc. \[KYMR\] Slides Release — Aug. 5 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [KYMR.US](https://longbridge.com/en/quote/KYMR.US.md)

## Related News & Research

- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [DE: 3Q 2026 saw sales and profit growth, but FY 2026 guidance signals industry headwinds](https://longbridge.com/en/news/296475895.md)
- [Public Storage announces R$ 0.41 per unit dividend for Q3 2026](https://longbridge.com/en/news/296635332.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**